DLEU2 Modulates Proliferation, Migration and Invasion of Platelet-derived Growth Factor-BB (PDGF-BB)-induced Vascular Smooth Muscle Cells (VSMCs) Via MiR-212-5p/YWHAZ Axis

Overview

Journal Cell Cycle

Specialty Cell Biology

Date 2022 Jul 1

PMID 35775826

Authors

Zhiying Zhao

Guangming Zhang

Jing Yang

Rui Lu

Haijuan Hu

Affiliations

Soon will be listed here.

Abstract

DLEU2 has been proved to act as an oncogene in a variety of cancers, but its role in cardiovascular diseases is dearth of research. Thus, this study mainly discussed the effect and possible mechanism of DLEU2 on platelet-derived growth factor-BB (PDGF-BB)-triggered vascular smooth muscle cell (VSMC) injury. To obtain authentic results, the expressions of target genes in atherosclerosis serum were determined by reverse transcription quantitative PCR (RT-qPCR) and the protein levels were evaluated by Western blot. PDGF-BB was used to simply simulate the biological characteristics of VSMCs . The effect of DLEU2 on the biological behavior of PDGF-BB-induced VSMCs was analyzed by gain- and loss-of-function assays. Bioinformatics analysis, dual luciferase reporter assay, and correlation method were conducted to determine the relationship between target genes. The role of DLEU2/miR-212-5p/ YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta) axis in PDGF-BB-induced VSMCs was verified by rescue experiments. As a result, DLEU2 and YWHAZ were up-regulated, and miR-212-5p was down-regulated in atherosclerosis serum. Overexpressed DLEU2 facilitated the biological behavior of PDGF-BB-induced VSMCs, whilst siDLEU2 did the opposite. Moreover, overexpressed DLEU2 promoted proliferating cell nuclear antigen (PCNA) expression but repressed α-smooth muscle actin (α-SMA) and Calponin expressions, while it also enhanced YWHAZ expression via suppressing miR-212-5p. MiR-212-5p mimic and siYWHAZ reversed the effects of overexpressed DLEU2 on above biological characteristics and protein expressions in PDGF-BB-induced VSMCs, while the regulatory effect of miR-212-5p mimic was partially offset by overexpressed YWHAZ. Collectively, DLEU2 modulates PDGF-BB-induced VSMC injury via miR-212-5p/YWHAZ axis in atherosclerosis.

Citing Articles

Targeting PDGF/PDGFR Signaling Pathway by microRNA, lncRNA, and circRNA for Therapy of Vascular Diseases: A Narrow Review.

Ma C, Shi S, Zhang X, Xin G, Zou X, Li W Biomolecules. 2024; 14(11).

PMID: 39595622 PMC: 11592287. DOI: 10.3390/biom14111446.

Elucidating VSMC phenotypic transition mechanisms to bridge insights into cardiovascular disease implications.

Xin Y, Zhang Z, Lv S, Xu S, Liu A, Li H Front Cardiovasc Med. 2024; 11:1400780.

PMID: 38803664 PMC: 11128571. DOI: 10.3389/fcvm.2024.1400780.

MicroRNA miR-212-5p Regulates the MEK/ERK Signaling Pathway by Targeting A-Raf proto-oncogene serine/threonine-protein kinase () to Regulate Cowshed PM-Induced NR8383 Apoptosis.

Sun K, Sun Y, Jia Y, Duan X, Ma Z, Zhang X Toxics. 2023; 11(12).

PMID: 38133382 PMC: 10748134. DOI: 10.3390/toxics11120981.

References

Wang T, Chen K, Hsu P, Lin H, Wang Y, Chen C . microRNA let-7g suppresses PDGF-induced conversion of vascular smooth muscle cell into the synthetic phenotype. J Cell Mol Med. 2017; 21(12):3592-3601. PMC: 5706591. DOI: 10.1111/jcmm.13269. View

Frostegard J . Immunity, atherosclerosis and cardiovascular disease. BMC Med. 2013; 11:117. PMC: 3658954. DOI: 10.1186/1741-7015-11-117. View

Zhou Y, He X, Liu R, Qin Y, Wang S, Yao X . LncRNA CRNDE regulates the proliferation and migration of vascular smooth muscle cells. J Cell Physiol. 2019; 234(9):16205-16214. DOI: 10.1002/jcp.28284. View

Liu K, Liu C, Zhang Z . lncRNA GAS5 acts as a ceRNA for miR-21 in suppressing PDGF-bb-induced proliferation and migration in vascular smooth muscle cells. J Cell Biochem. 2019; 120(9):15233-15240. DOI: 10.1002/jcb.28789. View

Dong X, Hu H, Fang Z, Cui J, Liu F . CTRP6 inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration. Biomed Pharmacother. 2018; 103:844-850. DOI: 10.1016/j.biopha.2018.04.112. View

Arnoldi R, Hiltbrunner A, Dugina V, Tille J, Chaponnier C . Smooth muscle actin isoforms: a tug of war between contraction and compliance. Eur J Cell Biol. 2013; 92(6-7):187-200. DOI: 10.1016/j.ejcb.2013.06.002. View

Choe K, Moldovan G . Forging Ahead through Darkness: PCNA, Still the Principal Conductor at the Replication Fork. Mol Cell. 2017; 65(3):380-392. PMC: 5302417. DOI: 10.1016/j.molcel.2016.12.020. View

Shan K, Jiang Q, Wang X, Wang Y, Yang H, Yao M . Role of long non-coding RNA-RNCR3 in atherosclerosis-related vascular dysfunction. Cell Death Dis. 2016; 7(6):e2248. PMC: 5143375. DOI: 10.1038/cddis.2016.145. View

Poller W, Dimmeler S, Heymans S, Zeller T, Haas J, Karakas M . Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives. Eur Heart J. 2017; 39(29):2704-2716. PMC: 6454570. DOI: 10.1093/eurheartj/ehx165. View

10.

Zhang W, Liu D, Han X, Ren J, Zhou P, Ding P . MicroRNA-451 inhibits vascular smooth muscle cell migration and intimal hyperplasia after vascular injury via Ywhaz/p38 MAPK pathway. Exp Cell Res. 2019; 379(2):214-224. DOI: 10.1016/j.yexcr.2019.03.033. View

11.

Hansson G, Hermansson A . The immune system in atherosclerosis. Nat Immunol. 2011; 12(3):204-12. DOI: 10.1038/ni.2001. View

12.

Togliatto G, Dentelli P, Rosso A, Lombardo G, Gili M, Gallo S . PDGF-BB Carried by Endothelial Cell-Derived Extracellular Vesicles Reduces Vascular Smooth Muscle Cell Apoptosis in Diabetes. Diabetes. 2018; 67(4):704-716. DOI: 10.2337/db17-0371. View

13.

Guo Y, Bai M, Lin L, Huang J, An Y, Liang L . LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2. Biomed Pharmacother. 2019; 118:109272. DOI: 10.1016/j.biopha.2019.109272. View

14.

Deng J, Zheng G, Li H, Ji Z . MiR-212-5p inhibits the malignant behavior of clear cell renal cell carcinoma cells by targeting TBX15. Eur Rev Med Pharmacol Sci. 2019; 23(24):10699-10707. DOI: 10.26355/eurrev_201912_19770. View

15.

Xu B, Gong X, Zi L, Li G, Dong S, Chen X . Silencing of DLEU2 suppresses pancreatic cancer cell proliferation and invasion by upregulating microRNA-455. Cancer Sci. 2019; 110(5):1676-1685. PMC: 6501038. DOI: 10.1111/cas.13987. View

16.

Arslan S, Berkan O, Lalem T, Ozbilum N, Goksel S, Korkmaz O . Long non-coding RNAs in the atherosclerotic plaque. Atherosclerosis. 2017; 266:176-181. DOI: 10.1016/j.atherosclerosis.2017.10.012. View

17.

Wang Y, Song X, Li Z, Liu B . Long non-coding RNAs in coronary atherosclerosis. Life Sci. 2018; 211:189-197. DOI: 10.1016/j.lfs.2018.08.072. View

18.

Ballantyne M, McDonald R, Baker A . lncRNA/MicroRNA interactions in the vasculature. Clin Pharmacol Ther. 2016; 99(5):494-501. PMC: 4881297. DOI: 10.1002/cpt.355. View

19.

Bennett M, Sinha S, Owens G . Vascular Smooth Muscle Cells in Atherosclerosis. Circ Res. 2016; 118(4):692-702. PMC: 4762053. DOI: 10.1161/CIRCRESAHA.115.306361. View

20.

Zhou Y, Shi H, Du Y, Zhao G, Wang X, Li Q . lncRNA DLEU2 modulates cell proliferation and invasion of non-small cell lung cancer by regulating miR-30c-5p/SOX9 axis. Aging (Albany NY). 2019; 11(18):7386-7401. PMC: 6781974. DOI: 10.18632/aging.102226. View